Top Premarket Gainers : vimarsana.com

-- C4 Therapeutics surged 59% premarket on Tuesday, following a license and research collaboration agreement with Merck to develop degrader-antibody conjugates.
Icosavax shares soared 47%,...

Related Keywords

, Therapeutics Inc , Protein Degrader Optimizer , Markets ,